MICHAEL GIBLIN: Open Payments
NPI 1366817611 · WHITE HOUSE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 63 payments from 15 companies in 2025. Trend: 2023 $511 · 2024 $1,438 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $276 |
| ABBVIE INC. | 17 | $187 |
| Medtronic, Inc. | 1 | $149 |
| Astellas Pharma US Inc | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 3 | $82 |
| PFIZER INC. | 4 | $66 |
| Boston Scientific Corporation | 2 | $59 |
| Amgen Inc. | 4 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Exact Sciences Corporation | 3 | $45 |
Products named: Ozempic, UBRELVY, MINIMED 780G, Veozah, REXULTI, Wegovy, WaveWriter Alpha Prime 16, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
